Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Luo, Xiaoya ^a,b   Stock, Christian ^a   Burwinkel, Barbara ^a,c   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 133A; MICRORNA 143; MICRORNA 145; MICRORNA 181B; MICRORNA 18A; MICRORNA 20A; MICRORNA 21; MICRORNA 29A; MICRORNA 342 3P; MICRORNA 532 3P; MICRORNA 92A; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD LEVEL; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877781097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062880     Document Type: Article

References (54)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Gupta AK, Brenner DE, Turgeon DK, (2008) Early detection of colon cancer: new tests on the horizon. Mol Diagn Ther 12: 77-85.
3. Pawa N, Arulampalam T, Norton JD, (2011) Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol 8: 711-22.
4. Hundt S, Haug U, Brenner H, (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 16: 1935-53.
5. Tao S, Hundt S, Haug U, Brenner H, (2011) Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease. Am J Gastroenterol 106: 242-53.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-97.
7. Garzon R, Marcucci G, Croce CM, (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9: 775-89.
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-8.
9. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-26.
10. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-81.
11. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, et al. (2010) Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25: 1674-80.
12. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M, (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154: 22-30.
13. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M, (2011) Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 29: 3761-7.
14. Hundt S, Haug U, Brenner H, (2009) Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150: 162-9.
15. Brenner H, Tao S, Haug U, (2010) Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 304: 2513-20.
16. Brenner H, Haug U, Hundt S, (2010) Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 127: 1643-9.
17. Luo X, Burwinkel B, Tao S, Brenner H, (2011) MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 20: 1272-86.
18. Turchinovich A, Weiz L, Langheinz A, Burwinkel B, (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-33.
19. Kroh EM, Parkin RK, Mitchell PS, Tewari M, (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
20. Efron B, Tibshirani R, (1997) Improvements on cross-validation: The.632+ bootstrap method. J Am Stat Assoc. 92: 548-60.
21. Adler W, Lausen B, (2009) Bootstrap estimated true and false positive rates and ROC curve. Comput Stat Data An 53: 718-29.
22. Canty A, Ripley B (2012) boot: bootstrap R (S-Plus) functions. R package version 1.3-4. Available: http://CRAN.R-project.org/package=boot. Accessed 27 Jul 2012.
23. Potapov S, Adler W, Lausen B (2012) Daim: Diagnostic accuracy of classification models. R package version 1.0.0. Available: http://CRAN.R-project.org/package=Daim. Accessed 24 Jun 2012.
24. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009 9: 374.
25. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, et al. (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101: 707-14.
26. Schmitz KJ, Hey S, Schinwald A, Wohlschlaeger J, Baba HA, et al. (2009) Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Virchows Arch 455: 49-54.
27. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402.
28. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-36.
29. Chen X, Guo X, Zhang H, Xiang Y, Chen J, et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-92.
30. Earle JS, Luthra R, Romans A, Abraham R, Ensor J, et al. (2010) Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn 12: 433-40.
31. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, et al. (2010) Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 200: 154-60.
32. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-75.
33. Wang J, Chen J, Chang P, LeBlanc A, Li D, et al. (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2: 807-13.
34. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, et al. (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706.
35. Ali S, Almhanna K, Chen W, Philip PA, Sarkar FH, (2010) Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 3: 28-47.
36. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, et al. (2011) Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PloS One 6: e26971.
37. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, et al. (2011) Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PloS One 6: e17745.
38. Cui L, Qi Y, Li H, Ge Y, Zhao K, et al. (2011) Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PloS One 6: e27071.
39. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-84.
40. Fu Y, Yi Z, Wu X, Li J, Xu F, (2011) Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49: 4246-51.
41. Huang JJ, Yu J, Li JY, Liu YT, Zhong RQ, (2012) Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Med Oncol. 29: 2402-8.
42. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 105: 104-11.
43. Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, et al. (2011) Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 105: 1733-40.
44. Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, et al. (2010) Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int 60: 351-7.
45. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, et al. (2009) Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PloS One 4: e5532.
46. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-9.
47. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-66.
48. Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, et al. (2011) Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 30: 407-14.
49. Yaman Agaoglu F, Kovancilar M, Dizdar Y, Darendeliler E, Holdenrieder S, et al. (2011) Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol 32: 583-8.
50. Zhou J, Yu L, Gao X, Hu J, Wang J, et al. (2011) Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29: 4781-8.
51. Wang J, Chen J, Chang P, LeBlanc A, Li D, et al. (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Cancer Prev Res 2: 807-13.
52. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-58.
53. Georgescu MM, (2010) PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. Genes Cancer 1: 1170-7.
54. Tao S, Haug U, Kuhn K, Brenner H, (2012) Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening. Br J Cancer 106: 1424-30.